BOSTON--(BUSINESS WIRE)--Jeffrey Frelick, analyst for Lazard Capital Markets, will discuss Enzo Biochem (NYSE: ENZ) Friday on CRN Cable Radio at 10:30 Eastern Time, 7:30 Pacific Time. Enzo Biochem is a company that has been discussed on this show and recommended by Princeton Research for the better part of the past year.
